HG-1007

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1007

Drug Alias NameCPP32 modulator (Human Genome Sciences)PARP cleavage protease modulator (Human Genome Sciences)aopoain modulator (Human Genome Sciences)apoptosis-related cysteine protease modulator (Human Genome Sciences)CASP3 modulator (Human Genome Sciences) +[9]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCaspase-3 modulators

TargetsCaspase-3

Therapy Area/IndicationsNervous System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A